Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Benchmark Initiates Coverage On Tencent Music Enter Gr with Hold Rating

Benchmark analyst Fawne Jiang initiates coverage on Tencent Music Enter Gr (NYSE:TME) with a Hold rating.

byBenzinga Newsdesk

December 28, 2021

1 minute read

Benchmark analyst Fawne Jiang initiates coverage on Tencent Music Enter Gr (NYSE:TME) with a Hold rating.

Perma-Pipe International Holdings, Inc. Announces Share Repurchase Program Of $965 Thousand

By Benzinga Newsdesk

Today, 10:51 PM

Perma-Pipe International Holdings, Inc. (NASDAQ:PPIH) (the "Company") announced today that its Board of Directors has authorized the use of $965 thousand remaining under the share repurchase program

PPIH

Neurocrine Biosciences Buys UK-Based Hormone Therapy Player

By Vandana Singh

Today, 10:51 PM

Neurocrine Biosciences Inc (NASDAQ:NBIX) has agreed to pay £48.3 million for the U.K. hormone therapy group, Diurnal Group Plc. The 27.5p share…

NBIX

A Peek Into The Markets: US Stock Futures Gain; All Eyes On Fed Decision

By Lisa Levin

Today, 10:51 PM

Pre-open movers

ACAD

Morgan Stanley Maintains Overweight on Arcutis Biotherapeutics, Raises Price Target to $49

By Benzinga Newsdesk

Today, 10:51 PM

Morgan Stanley analyst Vikram Purohit maintains Arcutis Biotherapeutics (NASDAQ:ARQT) with a Overweight and raises the price target from $46 to $49.

ARQT

Benchmark Initiates Coverage On Tencent Music Enter Gr with Hold Rating

Related Posts

Perma-Pipe International Holdings, Inc. Announces Share Repurchase Program Of $965 Thousand

Neurocrine Biosciences Buys UK-Based Hormone Therapy Player

A Peek Into The Markets: US Stock Futures Gain; All Eyes On Fed Decision

Morgan Stanley Maintains Overweight on Arcutis Biotherapeutics, Raises Price Target to $49